首页> 美国卫生研究院文献>Scientific Data >Multi-omic profiles of human non-alcoholic fatty liver disease tissue highlight heterogenic phenotypes
【2h】

Multi-omic profiles of human non-alcoholic fatty liver disease tissue highlight heterogenic phenotypes

机译:人类非酒精性脂肪肝疾病组织的多组学概况突出了异源表型

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Non-alcoholic fatty liver disease (NAFLD) is a consequence of sedentary life style and high fat diets with an estimated prevalence of about 30% in western countries. It is associated with insulin resistance, obesity, glucose intolerance and drug toxicity. Additionally, polymorphisms within, e.g., APOC3, PNPLA3, NCAN, TM6SF2 and PPP1R3B, correlate with NAFLD. Several studies have already investigated later stages of the disease. This study explores the early steatosis stage of NAFLD with the aim of identifying molecular mechanisms underlying the etiology of NAFLD. We analyzed liver biopsies and serum samples from patients with high- and low-grade steatosis (also pre-disease states) employing transcriptomics, ELISA-based serum protein analyses and metabolomics. Here, we provide a detailed description of the various related datasets produced in the course of this study. These datasets may help other researchers find new clues for the etiology of NAFLD and the mechanisms underlying its progression to more severe disease states.
机译:非酒精性脂肪肝病(NAFLD)是久坐的生活方式和高脂饮食的结果,据估计西方国家的患病率约为30%。它与胰岛素抵抗,肥胖,葡萄糖不耐症和药物毒性有关。另外,例如APOC3,PNPLA3,NCAN,TM6SF2和PPP1R3B内的多态性与NAFLD相关。几项研究已经研究了该疾病的晚期。这项研究探讨了NAFLD的早期脂肪变性阶段,目的是确定NAFLD病因的分子机制。我们使用转录组学,基于ELISA的血清蛋白分析和代谢组学分析了高脂和低脂脂肪变性(也属于疾病前状态)患者的肝活检和血清样品。在这里,我们提供了在此研究过程中产生的各种相关数据集的详细描述。这些数据集可以帮助其他研究人员找到有关NAFLD病因及其发展为更严重疾病状态的潜在机制的新线索。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号